Pharmacological treatment in chronic obstructive pulmonary disease

Current Respiratory Medicine Reviews

Volumn 4, Issue 4, 2008, Pages 301-311

  Laveneziana, Pierantonio ^a   Jensen, Dennis ^a   Webb, Katherine ^a   O'Donnell, Denis E ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Bronchodilators; COPD; Dynamic hyperinflation; Dyspnea; Exercise capacity; Heliox; Oxygen; Respiratory mechanics; Spirometry

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; FORMOTEROL; HELIOX; HELIUM; LONG ACTING DRUG; OXYGEN; PLACEBO; SALBUTAMOL; SALMETEROL; SHORT ACTING DRUG; TIOTROPIUM BROMIDE;

AMBIENT AIR; ARTERIAL OXYGEN SATURATION; BREATHING MECHANICS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DRUG ACTIVITY; DYSPNEA; EXERCISE; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HEART OUTPUT; HEART PERFORMANCE; HUMAN; HYPERINFLATION; HYPEROXIA; INSPIRATORY CAPACITY; INSPIRATORY RESERVE VOLUME; LUNG CAPACITY; LUNG VASCULAR RESISTANCE; LUNG VOLUME; OXYGEN CONSUMPTION; OXYGEN THERAPY; PRIORITY JOURNAL; RESPIRATORY DRIVE; REVIEW; TIDAL VOLUME;

EID: 65949109296     PISSN: 1573398X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339808786263833     Document Type: Review

References (77)

1. Pellegrino R, Viegi G, Brusasco V, et al. ATS/ERS Task Force. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-68.
2. O'Donnell D, Flüge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23: 832-40.
3. Maltais F, Hamilton A, Marciniuk D, et al. Improvements in symptom-limited exercise performance over eight hours with once-daily tiotropium in patients with COPD. Chest 2005; 128: 1168-78.
4. O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in COPD. Am J Respir Crit Care Med 1999; 160: 524-49.
5. Newton M, O'Donnell DE, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest 2002; 121: 1042-50.
6. Tantucci C, Duguet A, Similowski T, Zelter M, Derenne JP, Milic-Emili J. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J 1998; 12: 799-804.
7. Celli B, ZuWallack R, Wang S, Kesten S. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest 2003; 124: 1743-8.
8. O'Donnell DE, Forkert L, Webb KA. Evaluation of bronchodilator responses in patients with "irreversible emphysema". Eur Respir J 2001; 18: 914-20.
9. Peters MM, Webb KA, O'Donnell DE. Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD. Thorax 2006; 61: 559-67.
10. O'Donnell DE, Voduc N, Fitzpatrick M, Webb KA. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 2004; 24: 86-94.
11. O'Donnell DE, Hamilton AL, Webb KA. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. J Appl Physiol 2006; 101: 1025-35.
12. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 967-75.
13. Chrystyn H, Mulley BA, Peake MD. Dose response relation to oral theophylline in severe chronic obstructive airways disease. Brit Med J 1988; 297: 1506-10.
14. O'Donnell DE, Sciurba F, Celli B, et al. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest 2006; 130: 647-56.
15. van Noord JA, Aumann JL, Janssens E, et al. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. Chest 2006; 129: 509-17.
16. Diaz O, Villafranca C, Ghezzo H, et al. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitations at rest. Eur Respir J 2000; 16: 269-75.
17. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1557-65.
18. Saito S, Miyamoto K, Nishimura M, et al. Effects of inhaled bronchodilators on pulmonary hemodynamics at rest and during exercise in patients with COPD. Chest 1999; 115: 376-82.
19. Man WDC, Mustfa N, Nikoletou D, et al. Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD. Thorax 2004; 59: 471-6.
20. Travers J, Laveneziana P, Webb KA, Kesten S, O'Donnell DE. Effect of tiotropium bromide on the cardiovascular response to exercise in COPD. Respir Med 2007; 101: 2017-24.
21. Gandevia SC. The perception of motor commands on effort during muscular paralysis. Brain 1982; 105: 151-95.
22. Chen Z, Eldridge FL, Wagner PG. Respiratory associated rhythmic firing of midbrain neurons in cats: relation to level of respiratory drive. J Physiol 1991; 437: 305-25.
23. Campbell EJM, Howell JBL. The sensation of breathlessness. Br Med Bull 1963; 18: 36-40.
24. Chen Z, Eldridge FL, Wagner PG. Respiratory-associated thalamic activity is related to level of respiratory drive. Respir Physiol 1992; 90: 99-113.
25. O'Donnell DE, Hong HH, Webb KA. Respiratory sensation during chest wall restriction and dead space loading in exercising men. J Appl Physiol 2000; 88: 1859-69.
26. Davenport PW, Friedman WA, Thompson FJ, Franzen O. Respiratory-related cortical potentials evoked by inspiratory occlusion in humans. J Appl Physiol 1986; 60: 1843-8.
27. Zechman FR Jr, Wiley RL. Afferent inputs to breathing: respiratory sensation. In: AP Fishman, Ed. Handbook of Physiology, Section 3, Volume II, Part 2: The Respiratory System. Bethesda, MD: American Physiological Society, 1986; 449-74.
28. Chronos N, Adams L, Guz A. Effect of hyperoxia and hypoxia on exercise-induced breathlessness in normal subjects. Clin Sci 1988; 74: 531-7.
29. Lane R, Cockcroft A, Adams L, Guz A. Arterial oxygen saturation and breathlessness in patients with chronic obstructive airways disease. Clin Sci 1987; 72: 693-8.
30. Woodcock AA, Gross ER, Geddes DM. Oxygen relieves breathlessness in "pink puffers". Lancet 1981; 1: 907-9.
31. Stein DA, Bradley BL, Miller W. Mechanisms of oxygen effects on exercise in patients with chronic obstructive pulmonary disease. Chest 1982; 81: 6-10.
32. Libby DM, Briscoe WA, King TKC. Relief of hypoxia-related bronchoconstriction by breathing 30 percent oxygen. Am Rev Respir Dis 1981; 123: 171-5.
33. O'Donnell DE, D'Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 892-8.
34. O'Donnell DE, Bain DJ, Webb KA. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am J Respir Crit Care Med 1997; 155: 530-5.
35. Somfay A, Porszasz J, Lee SM, Casaburi R. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxemic COPD patients. Eur Respir J 2001; 18: 77-84.
36. Somfay A, Porszasz J, Lee SM, Casaburi R. Effect of hyperoxia on gas exchange and lactate kinetics following exercise onset in non-hypoxemic COPD patients. Chest 2002; 121: 393-400.
37. O'Donnell DE, Banzett RB, Carrieri-Kohlman V, et al. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thor Soc 2007; 4: 145-68.
38. 2 consumption in trained human skeletal muscle. J Appl Physiol 1999; 87: 325-31.
39. Amann M, Romer LM, Pegelow DF, Jacques AJ, Hess CJ, Dempsey JA. Effects of arterial oxygen content on peripheral locomotor muscle fatigue. J Appl Physiol 2006; 101: 119-27.
40. 31P-MRS study. J Appl Physiol 1999; 86: 1367-73.
41. 2. J Appl Physiol 1998; 85: 1457-63.
42. Mateika JH, Duffin J. The ventilation, lactate and electromyographic thresholds during incremental exercise tests in normoxia, hypoxia and hyperoxia. Eur J Appl Physiol 1994; 69: 110-8.
43. Amann M, Eldridge MW, Lovering AT, Stickland MK, Pegelow DF, Dempsey JA. Arterial oxygenation influences central motor output and exercise performance via effects on peripheral locomotor muscle fatigue in humans. J Physiol 2006; 573: 937-52.
44. Richardson RS, Sheldon J, Poole DC, Hopkins SR, Ries AL, Wagner PD. Evidence of skeletal muscle metabolic reserve during whole body exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 881-5.
45. Gosselin N, Durand F, Poulain M, et al. Effect of acute hyperoxia during exercise on quadriceps electrical activity in active COPD patients. Acta Physiol Scand 2004; 181: 333-43.
46. Maltais F, Simon M, Jobin J, et al. Effects of oxygen on lower limb blood flow and O2 uptake during exercise in COPD. Med Sci Sports Exerc 2001; 33: 916-22.
47. Eves ND, Petersen SR, Haykowsky MJ, Wong EY, Jones RL. Helium-hyperoxia, exercise, and respiratory mechanics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 174: 763-71.
48. Snider GL. Enhancement of exercise performance in COPD patients by hyperoxia: a call for research. Chest 2002; 122: 1830-6.
49. Saey D, Cote CH, Mador MJ, et al. Assessment of muscle fatigue during exercise in chronic obstructive pulmonary disease. Muscle Nerve 2006; 34: 62-71.
50. Payen JP, Wuyam P, Levy H, et al. Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia. Am Rev Respir Dis 1993; 147: 592-8.
51. 31P-MRS. J Appl Physiol 1995; 78: 2218-27.
52. Mador MJ, Bozkanat E, Kufel TJ. Quadriceps fatigues after cycle exercise in patients with COPD compared with healthy control subjects. Chest 2003; 123: 1104-11.
53. 2 during cycling exercise in COPD patients. J Appl Physiol 2001; 90: 1013-9.
54. Romer LM, Haverkamp HC, Lovering AT, Pegelow DF, Dempsey JA. Effect of exercise-induced arterial hypoxemia on quadriceps muscle fatigue in healthy humans. Am J Physiol Regul Integr Comp Physiol 2006; 290: R365-R375.
55. Stickland MK, Miller JD, Smith CA, Dempsey JA. Carotid chemoreceptor modulation of regional blood flow distribution during exercise in health and chronic heart failure. Circ Res 2007; 100: 1371-8.
56. Levison H, Cherniak RM. Ventilatory cost of exercise in chronic obstructive pulmonary disease. J Appl Physiol 1968; 25: 21-7.
57. Aaron EA, Seow KC, Johnson BD, Dempsey JA. Oxygen cost of hyperpnea: implications for performance. J Appl Physiol 1992; 72: 1818-25.
58. Oelberg DA, Medoff BD, Markowitz DH, Pappagianopoulos PP, Ginns LC, Systrom DM.. Systemic oxygen extraction during incremental exercise in patients with severe chronic obstructive pulmonary disease. Eur J Appl Physiol 1998; 78: 201-7.
59. Oelberg DA, Kacmarek RM, Pappagianopoulos PP, Ginns LC, Systrom DM. Ventilatory and cardiovascular responses to inspiratory He-O2 during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1876-82.
60. Guenette JA, Sheel AW. Physiological consequences of high work of breathing during heavy exercise in humans. J Sci Med Sport 2007; 10: 341-50.
61. Dempsey JA, Romer L, Rodman J, Miller J, Smith C. Consequences of exercise-induced respiratory muscle work. Respir Physiol Neurobiol 2006; 151: 242-50.
62. Harms CA, Babcock MA, McClaren SR, et al. Respiratory muscle work compromises leg blood flow during maximal exercise. J Appl Physiol 1997; 82: 1573-83.
63. Romer LM, Lovering AT, Haverkamp HC, Pegelow DF, Dempsey JA. Effect of inspiratory muscle work on peripheral fatigue of locomotor muscles in healthy humans. J Physiol 2006; 571: 425-39.
64. Barach AL. The use of helium in the treatment of asthma and obstructive lesions in the larynx and trachea. Ann Intern Med 1935; 9: 739-65.
65. Dawson SV, Elliott EA. Wave-speed limitation on expiratory flow - a unifying concept. J Appl Physiol 1977; 43: 498-515.
66. Pedley TJ, Schroter RC, Sudlow MF. Gas flow and mixing in the airways. West, JB eds. Bioengineering aspects of the lung. New York, NY: Marcel Dekker, 1977; 163-265.
67. Grapé B, Channin E, Tyler JM. The effect of helium and oxygen mixtures on pulmonary resistances in emphysema. Am Rev Respir Dis 1960; 81: 823-9.
68. Wouters EF, Landser FJ, Polko AH, Visser BF. Impedance measurement during air and helium-oxygen breathing before and after salbutamol. Clin Exp Pharmacol Physiol 1992; 19: 95-101.
69. Swidwa DM, Montenegro HD, Goldman MD, Lutchen KR, Saidel GM. Helium-oxygen breathing in severe chronic obstructive pulmonary disease. Chest 1985; 87: 790-5.
70. Meadows JA 3rd, Rodarte JR, Hyatt RE. Density dependence of maximal expiratory flow in chronic obstructive pulmonary disease. Am Rev Respir Dis 1980; 121: 47-53.
71. Marini JJ. Heliox in chronic obstructive pulmonary disease: time to lighten up? Crit Care Med 2000; 28: 3086-8.
72. Chevrolet JC. Helium oxygen mixtures in the intensive care unit. Crit Care 2001; 5: 179-81.
73. McClaran SR, Wetter TJ, Pegelow DF, Dempsey JA. Role of expiratory flow limitation in determining lung volumes and ventilation during exercise. J Appl Physiol 1999; 86: 1357-66.
74. 2. J Appl Physiol 1997; 82: 746-54.
75. Palange P, Valli G, Onorati P, et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol 2004; 97: 1637-42.
76. Marciniuk DD, Butcher SJ, Reid JK, et al. The effects of helium-hyperoxia on 6-min walking distance in COPD: a randomized, controlled trial. Chest 2007; 131: 1659-65.
77. Laude EA, Duffy NC, Baveystock C, et al. The effect of helium and oxygen on exercise performance in COPD: a randomised crossover trial. Am J Respir Crit Care Med 2006; 173: 865-70.